Flanders Cynthia 4
4 · ARGAN INC · Filed Jun 11, 2025
Insider Transaction Report
Form 4
ARGAN INCAGX
Flanders Cynthia
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-09$71.75/sh+7,053$506,053→ 31,634 total - Exercise/Conversion
Common Stock
2025-06-10+390→ 48,428 total - Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$46.35/sh−10,000$463,500→ 41,500 totalExercise: $46.35From: 2019-01-11Exp: 2028-01-11→ Common Stock (10,000 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$41.19/sh−10,000$411,900→ 31,500 totalExercise: $41.19From: 2019-12-12Exp: 2028-12-12→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2025-06-09$46.35/sh+8,096$375,250→ 39,730 total - Exercise/Conversion
Common Stock
2025-06-09$41.19/sh+8,308$342,207→ 48,038 total - Exercise/Conversion
Common Stock
2025-06-09$30.44/sh−10,000$304,400→ 61,500 totalExercise: $30.44From: 2017-01-07Exp: 2026-01-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2025-06-09$71.75/sh−10,000$717,500→ 51,500 totalExercise: $71.75From: 2018-01-05Exp: 2027-01-05→ Common Stock (10,000 underlying) - Exercise/Conversion
Time-Based Restricted Stock Units
2025-06-10−388→ 3,417 totalExercise: $0.00→ Common Stock (388 underlying) - Exercise/Conversion
Common Stock
2025-06-09$30.44/sh+8,749$266,320→ 24,581 total
Footnotes (5)
- [F1]On June 9, 2025, the Reporting Person exercised her stock option awarded on January 7, 2016 to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share, using the net settle method.
- [F2]On June 9, 2025, the Reporting Person exercised her stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method.
- [F3]On June 9, 2025, the Reporting Person exercised her stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method.
- [F4]On June 9, 2025, the Reporting Person exercised her stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method.
- [F5]Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends.